Skip to content

Most NNRTI-experienced patients in southern Africa will benefit from etravirine

Botswana PrEP trial will be unable to show if drugs block infection

HIV prevalence and risk behaviour varies between gay men in Southern and Eastern Europe

Half of new diagnoses in French gay men are recent infections

Continuous isoniazid preventive therapy (IPT) better at preventing TB than short-course in people with HIV

UNITAID approves patent pool for HIV drugs

Heavy drinking increases cardiovascular disease risk for men with HIV

Service integration, focus on holistic healthcare improves health indicators

Disappointment as microbicide fails to protect against HIV